It was shown that NF‐κB signaling targeting in TAMs was capable at inducing tumor‐killing activity in TAMs and activating anti‐tumor activity via recruitment of IL‐12‐dependent NK cells to promote tumor regression in vivo.41, 42. This evidence concerns the gene NFKB1 and neoplasm.